219 related articles for article (PubMed ID: 24492955)
1. Functional mutations in and characterization of VHH against Helicobacter pylori urease.
Hoseinpoor R; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Shahi B
Appl Biochem Biotechnol; 2014 Mar; 172(6):3079-91. PubMed ID: 24492955
[TBL] [Abstract][Full Text] [Related]
2. A novel nanobody against urease activity of Helicobacter pylori.
Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
[TBL] [Abstract][Full Text] [Related]
3. Selection of a fully human single domain antibody specific to Helicobacter pylori urease.
Fouladi M; Sarhadi S; Tohidkia M; Fahimi F; Samadi N; Sadeghi J; Barar J; Omidi Y
Appl Microbiol Biotechnol; 2019 Apr; 103(8):3407-3420. PubMed ID: 30810777
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and property study of the recombinant Camel anti-SpaA-N single domain antibodies].
Lu QX; Qing GL; Yang CJ; Xia XQ; Li JW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):55-8. PubMed ID: 22230504
[TBL] [Abstract][Full Text] [Related]
5. Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease.
Houimel M; Corthesy-Theulaz I; Fisch I; Wong C; Corthesy B; Mach J; Finnern R
Tumour Biol; 2001; 22(1):36-44. PubMed ID: 11054025
[TBL] [Abstract][Full Text] [Related]
6. Efficient production of nanobodies against urease activity ofHelicobacter pylori in Pichia pastoris.
Pourasadi S; Mousavi Gargari SL; Rajabibazl M; Nazarian S
Turk J Med Sci; 2017 Apr; 47(2):695-701. PubMed ID: 28425268
[TBL] [Abstract][Full Text] [Related]
7. Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.
Shahi B; Mousavi Gargari SL; Rasooli I; Rajabi Bazl M; Hoseinpoor R
J Appl Microbiol; 2014 Aug; 117(2):528-36. PubMed ID: 24766494
[TBL] [Abstract][Full Text] [Related]
8. Nanobodies: natural single-domain antibodies.
Muyldermans S
Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
[TBL] [Abstract][Full Text] [Related]
9. Introduction to heavy chain antibodies and derived Nanobodies.
Vincke C; Muyldermans S
Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
[TBL] [Abstract][Full Text] [Related]
10. Single domain camel antibodies: current status.
Muyldermans S
J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
[TBL] [Abstract][Full Text] [Related]
11. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
Ahmadvand D; Rahbarizadeh F; Vishteh VK
Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
[TBL] [Abstract][Full Text] [Related]
12. A camel anti-lysozyme CDR3 only domain antibody selected from phage display VHH library acts as potent lysozyme inhibitor.
Qiu L; Feng Y; Ma X; Li J
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):513-519. PubMed ID: 28475681
[TBL] [Abstract][Full Text] [Related]
13. Specific degradation of H. pylori urease by a catalytic antibody light chain.
Hifumi E; Hatiuchi K; Okuda T; Nishizono A; Okamura Y; Uda T
FEBS J; 2005 Sep; 272(17):4497-505. PubMed ID: 16128818
[TBL] [Abstract][Full Text] [Related]
14. Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF.
Ebrahimizadeh W; Mousavi Gargari SL; Javidan Z; Rajabibazl M
Appl Biochem Biotechnol; 2015 Aug; 176(7):1985-95. PubMed ID: 26054617
[TBL] [Abstract][Full Text] [Related]
15. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
16. Recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori-associated disease.
Fujii R; Morihara F; Fukushima K; Oku T; Hifumi E; Uda T
Biotechnol Bioeng; 2004 Jun; 86(7):737-46. PubMed ID: 15162449
[TBL] [Abstract][Full Text] [Related]
17. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
Xia X; M M; Zhai T; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical improvement of rabbit derived single-domain antibodies by substitutions with amino acids conserved in camelid antibodies.
Shinozaki N; Hashimoto R; Noda M; Uchiyama S
J Biosci Bioeng; 2018 Jun; 125(6):654-661. PubMed ID: 29398547
[TBL] [Abstract][Full Text] [Related]
20. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
